Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-030185

Chief Commercial Officer gave up 2,482 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Gayer Charles K · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-19 Shares withheld for taxes : show line 1 in the form −2,482 $6.05 $15,016 274,533 D
Loading xslF345X05/form4.xml…